Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmaceutical company funding and its consequences: a qualitative systematic review.

Literature DB >> 17919992

Pharmaceutical company funding and its consequences: a qualitative systematic review.

Abstract

This article systematically reviews published studies of the association of pharmaceutical industry funding and clinical trial results, as well a few closely related studies. It reviews two earlier results, and surveys the recent literature. Results are clear: Pharmaceutical company sponsorship is strongly associated with results that favor the sponsors' interests.

Mesh：

Year: 2007 PMID： 17919992 DOI： 10.1016/j.cct.2007.08.001

Source DB: PubMed Journal: Contemp Clin Trials ISSN： 1551-7144 Impact factor: 2.226

Keyword Cloud
Cited

76 in total

1. Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO.

Authors: Kay Dickersin; Iain Chalmers
Journal: J R Soc Med Date: 2011-12 Impact factor: 5.344

2. Patenting and the gender gap: should women be encouraged to patent more?

Authors: Inmaculada de Melo-Martín
Journal: Sci Eng Ethics Date: 2012-01-03 Impact factor: 3.525

3. The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.

Authors: Gisela Schott; Henry Pachl; Ulrich Limbach; Ursula Gundert-Remy; Wolf-Dieter Ludwig; Klaus Lieb
Journal: Dtsch Arztebl Int Date: 2010-04-23 Impact factor: 5.594

4. The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).

Authors: O Bruyere; J A Kanis; M-E Ibar-Abadie; N Alsayed; M L Brandi; N Burlet; D L Cahall; A Chines; J-P Devogelaer; W Dere; N Goel; N Hughes; J-M Kaufman; S Korte; B H Mitlak; D Niese; R Rizzoli; L C Rovati; J-Y Reginster
Journal: Osteoporos Int Date: 2010-03-18 Impact factor: 4.507

Pharmaceutical company funding and its consequences: a qualitative systematic review.

1. Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO.

2. Patenting and the gender gap: should women be encouraged to patent more?

3. The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.

4. The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).

Review 5. Qualitative research in medicine - An art to be nurtured.

6. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

7. Money makes the world go round: the pervasiveness of pharmacoeconomics.

8. Progressive licensing of drugs: music or noise?

Review 9. The nature and influence of pharmaceutical industry involvement in asthma trials.

10. Conflict of Interest and Funding Disclosure Policies of Environmental, Occupational, and Public Health Journals.